JP Morgan Chase
CLYM

JP Morgan Chase’s Climb Bio CLYM Stock Holding History

JP Morgan Chase’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$301 Hold
46
– – ﹤0.01% 7224
2025
Q4 		$184 Sell
46
-21,966
-100% -$52.7K ﹤0.01% 7165
2025
Q3 		$44.2K Sell
22,012
-188,110
-90% -$349K ﹤0.01% 6276
2025
Q2 		$261K Sell
210,122
-96,302
-31% -$120K ﹤0.01% 5105
2025
Q1 		$374K Buy
306,424
+14,628
+5% +$23.7K ﹤0.01% 4946
2024
Q4 		$525K Buy
291,796
+279,020
+2,184% +$1.01M ﹤0.01% 5005
2024
Q3 		$65K Buy
12,776
+9,672
+312% +$68.4K ﹤0.01% 5893
2024
Q2 		$22.1K Buy
+3,104
New +$20.7K ﹤0.01% 6110
2024
Q1 		– Sell
-1
Closed -$3 – 7962
2023
Q4 		$3 Buy
+1
New +$3 ﹤0.01% 7464
2022
Q2 		– Sell
-2,829
Closed -$24K – 6959
2022
Q1 		$24K Sell
2,829
-205,199
-99% -$1.91M ﹤0.01% 6039
2021
Q4 		$2.18M Buy
208,028
+4,590
+2% +$68.4K ﹤0.01% 3796
2021
Q3 		$3.66M Buy
+203,438
New +$4.2M ﹤0.01% 3307

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return